scholarly article | Q13442814 |
P2860 | cites work | An integrated map of genetic variation from 1,092 human genomes | Q22122153 |
Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering | Q24655574 | ||
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
The genetics of major depression | Q26830784 | ||
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data | Q27860742 | ||
The Sequence Alignment/Map format and SAMtools | Q27860966 | ||
Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads | Q28296838 | ||
Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha | Q28513388 | ||
A mega-analysis of genome-wide association studies for major depressive disorder | Q29417093 | ||
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
LocusZoom: regional visualization of genome-wide association scan results | Q29614868 | ||
Molecular signatures of major depression | Q30412070 | ||
The epidemiology of depression across cultures | Q33908984 | ||
Genetic epidemiology of major depression: review and meta-analysis | Q33919509 | ||
Power and predictive accuracy of polygenic risk scores. | Q34337027 | ||
Further improvements to linear mixed models for genome-wide association studies | Q34504804 | ||
An integrative variant analysis pipeline for accurate genotype/haplotype inference in population NGS data | Q34538741 | ||
A comparison of melancholic and nonmelancholic recurrent major depression in Han Chinese women | Q36195814 | ||
The epidemiology of depression in metropolitan China. | Q37189893 | ||
Low prevalence of major depressive disorder in Taiwanese adults: possible explanations and implications. | Q40005640 | ||
Extremely low-coverage sequencing and imputation increases power for genome-wide association studies | Q41882858 | ||
Low-coverage sequencing: implications for design of complex trait association studies | Q42596059 | ||
Genetic and environmental risk factors for depression assessed by subject-rated symptom check list versus structured clinical interview | Q44884819 | ||
Clinical indices of familial depression in the Swedish Twin Registry | Q44927127 | ||
The diagnostic validity of melancholic major depression in a population-based sample of female twins | Q45103929 | ||
FaST linear mixed models for genome-wide association studies | Q46661213 | ||
Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality. | Q51907241 | ||
P433 | issue | 7562 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | whole genome sequencing | Q2068526 |
major depressive disorder | Q42844 | ||
P304 | page(s) | 588-91 | |
P577 | publication date | 2015-07-30 | |
P1433 | published in | Nature | Q180445 |
P1476 | title | Sparse whole-genome sequencing identifies two loci for major depressive disorder | |
P478 | volume | 523 |
Q37603810 | A Combined Pathway and Regional Heritability Analysis Indicates NETRIN1 Pathway Is Associated With Major Depressive Disorder |
Q98735787 | A Comprehensive Analysis of the Effect of SIRT1 Variation on the Risk of Schizophrenia and Depressive Symptoms |
Q57822446 | A Longitudinal Model of Human Neuronal Differentiation for Functional Investigation of Schizophrenia Polygenic Risk |
Q38783177 | A continuum of genetic liability for minor and major depression. |
Q38916885 | A current snapshot of common genomic variants contribution in psychiatric disorders |
Q95319271 | A genome-wide association study of interhemispheric theta EEG coherence: implications for neural connectivity and alcohol use behavior |
Q91359223 | A joint study of whole exome sequencing and structural MRI analysis in major depressive disorder |
Q36373005 | A latent genetic subtype of major depression identified by whole-exome genotyping data in a Mexican-American cohort |
Q38776510 | A method for the allocation of sequencing resources in genotyped livestock populations |
Q36306020 | A novel strategy for clustering major depression individuals using whole-genome sequencing variant data |
Q40283480 | A rare missense variant in RCL1 segregates with depression in extended families |
Q33553419 | A reference panel of 64,976 haplotypes for genotype imputation |
Q91583047 | ADHD and depression: investigating a causal explanation |
Q37102021 | Additive genetic risk from five serotonin system polymorphisms interacts with interpersonal stress to predict depression |
Q47606495 | Advancing psychiatric genetics through dissecting heterogeneity |
Q33885379 | Age of onset and family history as indicators of polygenic risk for major depression. |
Q50072499 | Alcohol Misuse Across the Lifespan: Insights from Developmental Studies in Behavior Genetics. |
Q60920695 | Allele Frequencies in Depressed Patients of European Descent in Russia |
Q51761638 | Altered DNA methylation associated with a translocation linked to major mental illness. |
Q40397660 | An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype |
Q39186841 | An astroglial basis of major depressive disorder? An overview. |
Q33791821 | An examination of the etiologic overlap between the genetic and environmental influences on insomnia and common psychopathology |
Q50032095 | An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction. |
Q48128009 | An xQTL map integrates the genetic architecture of the human brain's transcriptome and epigenome |
Q38626082 | Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry |
Q92185935 | Analysis of polygenic risk score usage and performance in diverse human populations |
Q92242987 | Analyzing the genes and pathways related to major depressive disorder via a systems biology approach |
Q38931373 | Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders. |
Q33635647 | Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data. |
Q91693285 | Association Analysis of 14 Candidate Gene Polymorphism with Depression and Stress among Gestational Diabetes Mellitus |
Q47380198 | Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort. |
Q61849573 | Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population. |
Q93002221 | Association of SYNE1 locus with bipolar disorder in Chinese population |
Q57515292 | Association of Whole-Genome and NETRIN1 Signaling Pathway–Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank |
Q64298943 | Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents: A Voxelwise and Genome-Wide Association Study |
Q30363301 | Association of polygenic risk for major psychiatric illness with subcortical volumes and white matter integrity in UK Biobank |
Q38837222 | Associations Between Dopamine D2 Receptor (DRD2) Gene, Maternal Positive Parenting and Trajectories of Depressive Symptoms from Early to Mid-Adolescence |
Q64239350 | Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling |
Q40170492 | BDNFVal66met polymorphism: a potential bridge between depression and thrombosis |
Q57143143 | BK channel deacetylation by SIRT1 in dentate gyrus regulates anxiety and response to stress |
Q93050179 | Bibliography: Depression: Challenges and Treatments |
Q60643583 | Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression |
Q91773699 | Brain Banks Spur New Frontiers in Neuropsychiatric Research and Strategies for Analysis and Validation |
Q48067509 | Brain-derived neurotrophic factor Val66Met polymorphism in depression and thrombosis: SIRT1 as a possible mediator |
Q94562501 | Brain-specific Wt1 deletion leads to depressive-like behaviors in mice via the recruitment of Tet2 to modulate Epo expression |
Q39825160 | CHRONICITY OF DEPRESSION AND MOLECULAR MARKERS IN A LARGE SAMPLE OF HAN CHINESE WOMEN. |
Q59068655 | China’s crackdown on genetics breaches could deter data sharing |
Q53668059 | Cognitive genomics: Linking genes to behavior in the human brain. |
Q38863541 | Common Genetic Variation Near Melatonin Receptor 1A Gene Linked to Job-Related Exhaustion in Shift Workers |
Q47334914 | Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disorders. |
Q39710652 | Common variants in CACNA1C and MDD susceptibility: A comprehensive meta-analysis. |
Q37236662 | Common variants in FKBP5 gene and major depressive disorder (MDD) susceptibility: a comprehensive meta-analysis |
Q57316757 | Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder |
Q91330217 | Comparative genetic architectures of schizophrenia in East Asian and European populations |
Q35804142 | Comparative genome-wide association studies of a depressive symptom phenotype in a repeated measures setting by race/ethnicity in the Multi-Ethnic Study of Atherosclerosis |
Q91585548 | Complement C7 is a novel risk gene for Alzheimer's disease in Han Chinese |
Q60632104 | Continuity of genetic and environmental influences on clinically assessed major depression from ages 18 to 45 |
Q90575529 | Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry |
Q57697817 | Convergence of evidence from a methylome-wide CpG-SNP association study and GWAS of major depressive disorder |
Q47389484 | Copy number variation meta-analysis reveals a novel duplication at 9p24 associated with multiple neurodevelopmental disorders |
Q56337964 | Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression |
Q56992616 | DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies |
Q36485741 | DNA methylation in a Scottish family multiply affected by bipolar disorder and major depressive disorder |
Q61443156 | DNA methylation in the human frontal cortex reveals a putative mechanism for age-by-disease interactions |
Q30400681 | DSM disorders and their criteria: how should they inter-relate? |
Q92555462 | Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders |
Q58617330 | Depression |
Q49912400 | Depression and obesity: evidence of shared biological mechanisms. |
Q90182946 | Depression genetic risk score is associated with anhedonia-related markers across units of analysis |
Q92621397 | Development and challenges of mental health in China |
Q30235350 | Development of depression in survivors of childhood and adolescent cancer: a multi-level life course conceptual framework. |
Q90304075 | Differential associations of depression-related phenotypes with cardiometabolic risks: Polygenic analyses and exploring shared genetic variants and pathways |
Q36559255 | Disease and Polygenic Architecture: Avoid Trio Design and Appropriately Account for Unscreened Control Subjects for Common Disease |
Q38623862 | Do regional brain volumes and major depressive disorder share genetic architecture? A study of Generation Scotland (n=19 762), UK Biobank (n=24 048) and the English Longitudinal Study of Ageing (n=5766). |
Q46643230 | Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium |
Q47264713 | Drp1 Mitochondrial Fission in D1 Neurons Mediates Behavioral and Cellular Plasticity during Early Cocaine Abstinence |
Q38804179 | EBT: A Statistic Test Identifying Moderate Size of Significant Features with Balanced Power and Precision for Genome-wide Rate Comparisons |
Q48065412 | Effect of the interaction between childhood abuse and rs1360780 of the FKBP5 gene on gray matter volume in a general population sample |
Q92759312 | Effects of the LHPP gene polymorphism on the functional and structural changes of gray matter in major depressive disorder |
Q104795298 | Efficient phasing and imputation of low-coverage sequencing data using large reference panels |
Q37611719 | Emerging Molecular Pathways Governing Dietary Regulation of Neural Stem Cells during Aging. |
Q31108294 | Empirical estimation of genome-wide significance thresholds based on the 1000 Genomes Project data set |
Q47572896 | Epigenetic mechanisms of major depression: Targeting neuronal plasticity. |
Q41573772 | Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides |
Q42705159 | Estimation of kinship coefficient in structured and admixed populations using sparse sequencing data. |
Q38917988 | Evidence of AS3MTd2d3-Associated Variants within 10q24.32-33 in the Genetic Risk of Major Affective Disorders |
Q63728363 | Evidence of causal effect of major depression on alcohol dependence: findings from the psychiatric genomics consortium |
Q39588010 | Exome-sequencing in a large population-based study reveals a rare Asn396Ser variant in the LIPG gene associated with depressive symptoms. |
Q38668022 | Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist |
Q41951157 | Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7. |
Q39033094 | Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits |
Q33716821 | Extremely low-coverage whole genome sequencing in South Asians captures population genomics information |
Q37048022 | Fast and accurate long-range phasing in a UK Biobank cohort |
Q64917597 | Finding associated variants in genome-wide association studies on multiple traits. |
Q48078284 | First robust genetic links to depression emerge |
Q54966377 | From the Psychiatrist's Couch to Induced Pluripotent Stem Cells: Bipolar Disease in a Dish. |
Q89581678 | Further Evidence of an Association between NCAN rs1064395 and Bipolar Disorder |
Q90408062 | Further confirmation of netrin 1 receptor (DCC) as a depression risk gene via integrations of multi-omics data |
Q36782711 | GENOME-WIDE ASSOCIATION STUDY (GWAS) AND GENOME-WIDE BY ENVIRONMENT INTERACTION STUDY (GWEIS) OF DEPRESSIVE SYMPTOMS IN AFRICAN AMERICAN AND HISPANIC/LATINA WOMEN. |
Q38904425 | GW-SEM: A Statistical Package to Conduct Genome-Wide Structural Equation Modeling |
Q57159613 | GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort |
Q36542410 | GWAS of 89,283 individuals identifies genetic variants associated with self-reporting of being a morning person |
Q38600696 | Gene × Environment Determinants of Stress- and Anxiety-Related Disorders |
Q58786918 | Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP) |
Q38728415 | Genetic Approaches to Understanding Psychiatric Disease. |
Q36404519 | Genetic Control over mtDNA and Its Relationship to Major Depressive Disorder |
Q57077043 | Genetic Overlap Between Depression and Cardiometabolic Disorders |
Q28072645 | Genetic Pathways to Insomnia |
Q42699257 | Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression. |
Q38924066 | Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders. |
Q37249137 | Genetic and Environmental Factors Associated with Cannabis Involvement |
Q37339747 | Genetic and environmental components of female depression as a function of the severity of the disorder |
Q38961848 | Genetic and environmental influences on last-year major depression in adulthood: a highly heritable stable liability but strong environmental effects on 1-year prevalence |
Q58797784 | Genetic association and meta-analysis of a schizophrenia GWAS variant rs10489202 in East Asian populations |
Q33601878 | Genetic effects influencing risk for major depressive disorder in China and Europe |
Q61807449 | Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms |
Q38769614 | Genetic epidemiology of migraine and depression |
Q90146410 | Genetic heterogeneity in self-reported depressive symptoms identified through genetic analyses of the PHQ-9 |
Q47903939 | Genetic risk mechanisms of posttraumatic stress disorder in the human brain |
Q90431881 | Genetic stratification of depression by neuroticism: revisiting a diagnostic tradition |
Q38883299 | Genetic susceptibility to bilateral tinnitus in a Swedish twin cohort. |
Q91928661 | Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm |
Q36429824 | Genetical Genomics of Behavior: A Novel Chicken Genomic Model for Anxiety Behavior |
Q33840955 | Genetics of Depression: Progress at Last |
Q28072284 | Genetics of Tinnitus: An Emerging Area for Molecular Diagnosis and Drug Development |
Q41585015 | Genetics of disease: Associations with depression |
Q57041595 | Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect |
Q37603806 | Genome-wide Association for Major Depression Through Age at Onset Stratification: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium |
Q40353484 | Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder |
Q36932866 | Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci. |
Q52560096 | Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. |
Q33703868 | Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus |
Q47745726 | Genome-wide association studies of bipolar disorder: A systematic review of recent findings and their clinical implications. |
Q61805770 | Genome-wide association study identifies a novel locus associated with psychological distress in the Japanese population |
Q57032352 | Genome-wide association study identifies glutamate ionotropic receptor GRIA4 as a risk gene for comorbid nicotine dependence and major depression |
Q36067406 | Genome-wide association study of behavioral, physiological and gene expression traits in outbred CFW mice |
Q52584632 | Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways. |
Q52367035 | Genome-wide association study of depressive symptoms in the Hispanic Community Health Study/Study of Latinos. |
Q39783086 | Genome-wide association study of generalized anxiety symptoms in the Hispanic Community Health Study/Study of Latinos |
Q40367486 | Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1. |
Q46022556 | Genome-wide gene-environment interaction in depression: A systematic evaluation of candidate genes: The childhood trauma working-group of PGC-MDD. |
Q47394982 | Genome-wide haplotype-based association analysis of major depressive disorder in Generation Scotland and UK Biobank. |
Q60641775 | Genome-wide interaction study of a proxy for stress-sensitivity and its prediction of major depressive disorder |
Q28384381 | Genome-wide linkage on chromosome 10q26 for a dimensional scale of major depression |
Q47556039 | Genome-wide meta-analyses of stratified depression in Generation Scotland and UK Biobank. |
Q63433067 | Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions |
Q50421669 | Genome-wide scan of depressive symptomatology in two representative cohorts in the United States and the United Kingdom. |
Q49822467 | Genomewide association study of alcohol dependence and related traits in a Thai population. |
Q37735446 | Genomic Rearrangements in Arabidopsis Considered as Quantitative Traits |
Q90975802 | Genomic prediction of depression risk and resilience under stress |
Q58609986 | HPA-axis multilocus genetic variation moderates associations between environmental stress and depressive symptoms among adolescents |
Q47407332 | Heritability of major depressive and comorbid anxiety disorders in multi-generational families at high risk for depression |
Q38611730 | Heterogeneous stock rats: a model to study the genetics of despair-like behavior in adolescence. |
Q40097401 | High-Coverage Whole-Exome Sequencing Identifies Candidate Genes for Suicide in Victims with Major Depressive Disorder. |
Q38681922 | Histone Modifications in Major Depressive Disorder and Related Rodent Models. |
Q93077297 | How genome-wide association studies (GWAS) made traditional candidate gene studies obsolete |
Q38850402 | Human Genomic Signatures of Brain Oscillations During Memory Encoding |
Q47174305 | Huntingtin gene repeat size variations affect risk of lifetime depression |
Q54978040 | Identification and bioinformatics analysis of overlapping differentially expressed genes in depression, papillary thyroid cancer and uterine fibroids. |
Q39537609 | Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. |
Q57677495 | Identification of expression quantitative trait loci associated with schizophrenia and affective disorders in normal brain tissue |
Q64094594 | Identification of key genes, pathways, and miRNA/mRNA regulatory networks of CUMS-induced depression in nucleus accumbens by integrated bioinformatics analysis |
Q38664301 | Identifying and mitigating batch effects in whole genome sequencing data. |
Q36304801 | Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential |
Q56768819 | Imaging genetics paradigms in depression research: Systematic review and meta-analysis |
Q37642670 | Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder |
Q41548141 | Insight into the metabolic mechanism of Diterpene Ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxine. |
Q91644477 | Integration of GWAS and brain eQTL identifies FLOT1 as a risk gene for major depressive disorder |
Q91644471 | Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder |
Q60305503 | Intraday Activity Levels May Better Reflect the Differences Between Major Depressive Disorder and Bipolar Disorder Than Average Daily Activity Levels |
Q60915137 | Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study |
Q37717808 | Investigating shared aetiology between type 2 diabetes and major depressive disorder in a population based cohort |
Q88815629 | Is familial risk for depression confounded by individual and familial socioeconomic factors and neighborhood environmental factors? A 7-year follow-up study in Sweden |
Q90480293 | Kernel size-related genes revealed by an integrated eQTL analysis during early maize kernel development |
Q38821961 | Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability. |
Q52341028 | Low-frequency and rare variants may contribute to elucidate the genetics of major depressive disorder. |
Q91790213 | Mahuang-Fuzi-Xixin Decoction Reverses Depression-Like Behavior in LPS-Induced Mice by Regulating NLRP3 Inflammasome and Neurogenesis |
Q56962426 | Major depressive disorder |
Q26747013 | MeCP2 and the enigmatic organization of brain chromatin. Implications for depression and cocaine addiction |
Q89898091 | Measurement and genetic architecture of lifetime depression in the Netherlands as assessed by LIDAS (Lifetime Depression Assessment Self-report) |
Q92058771 | Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway |
Q88674385 | Method to estimate the approximate samples size that yield a certain number of significant GWAS signals in polygenic traits |
Q57697822 | Methylome-wide association findings for major depressive disorder overlap in blood and brain and replicate in independent brain samples |
Q39043211 | Methylomic profiling of cortex samples from completed suicide cases implicates a role for PSORS1C3 in major depression and suicide |
Q93350625 | MiR-155 is involved in major depression disorder and antidepressant treatment via targeting SIRT1 |
Q64255899 | Mineral Nutrition and the Risk of Chronic Diseases: A Mendelian Randomization Study |
Q90776484 | Minimal phenotyping yields genome-wide association signals of low specificity for major depression |
Q52370506 | Molecular Genetic Analysis Subdivided by Adversity Exposure Suggests Etiologic Heterogeneity in Major Depression. |
Q56976586 | Molecular genetic overlap between migraine and major depressive disorder |
Q39043771 | Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies |
Q39318173 | Mood, the Circadian System, and Melanopsin Retinal Ganglion Cells. |
Q47945647 | Moving forward: how depression heterogeneity hinders progress in treatment and research |
Q37695673 | Multivariate simulation framework reveals performance of multi-trait GWAS methods |
Q27339187 | Nature and nurture: environmental influences on a genetic rat model of depression |
Q28386468 | Neighborhood income and major depressive disorder in a large Dutch population: results from the LifeLines Cohort study |
Q46300803 | Neuroimaging genomics in psychiatry-a translational approach |
Q33602197 | Neuroinflammation-a co-occurring phenomenon linking chronic pain and opioid dependence |
Q37344755 | Neuropsychiatric genomics in precision medicine: diagnostics, gene discovery, and translation |
Q38954644 | Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance |
Q26749017 | Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review |
Q92760802 | Pathway-based polygene risk for severe depression implicates drug metabolism in CONVERGE |
Q37686555 | Patterns and correlates of major depression in Chinese adults: a cross-sectional study of 0.5 million men and women |
Q47750361 | Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression. |
Q92907278 | Pharmacogenetics and Depression: A Critical Perspective |
Q42361493 | Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry |
Q52630895 | Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences. |
Q36583679 | Polygenic interactions with environmental adversity in the aetiology of major depressive disorder. |
Q45069030 | Polygenic risk for severe psychopathology among Europeans is associated with major depressive disorder in Han Chinese women |
Q92957140 | Polygenic risk scores in schizophrenia with clinically significant copy number variants |
Q33682211 | Possible association between SIRT1 single nucleotide polymorphisms and predisposition to antisocial personality traits in Chinese adolescents |
Q88155978 | Predicting loneliness with polygenic scores of social, psychological and psychiatric traits |
Q90268467 | Prediction of adolescent subjective well-being: A machine learning approach |
Q47302028 | Predictive Psychiatric Genetic Testing in Minors: An Exploration of the Non-Medical Benefits |
Q49536721 | Prepubertal Ovariectomy Exaggerates Adult Affective Behaviors and Alters the Hippocampal Transcriptome in a Genetic Rat Model of Depression. |
Q89900613 | Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants |
Q36059819 | Probing the stress and depression circuits with a disease gene |
Q47147207 | Progress in Genetic Studies of Tourette's Syndrome |
Q50546035 | Psychiatric genetics: what's new in 2015? |
Q30362452 | Psychophysiology of threat response, paradigm shifts in psychiatry, and RDoC: Implications for genetic investigation of psychopathology. |
Q57175641 | Psychotherapy and Genetic Neuroscience: An Emerging Dialog |
Q37641087 | RETRACTED ARTICLE: 11,670 whole-genome sequences representative of the Han Chinese population from the CONVERGE project |
Q37138536 | Rapid genotype imputation from sequence without reference panels |
Q40519250 | Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015. |
Q40153548 | Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophrenia |
Q64884092 | Re-evaluating classical body type theories: genetic correlation between psychiatric disorders and body mass index. |
Q92511862 | Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway |
Q47171927 | Regulatory Pathways of Monoamine Oxidase A during Social Stress |
Q90665100 | Regulatory mechanisms of major depressive disorder risk variants |
Q37396696 | Relationship between the LHPP Gene Polymorphism and Resting-State Brain Activity in Major Depressive Disorder |
Q92982619 | Relationships among impulsive, addictive and sexual tendencies and behaviours: a systematic review of experimental and prospective studies in humans |
Q47758383 | Repetitive transcranial magnetic stimulation inhibits Sirt1/MAO-A signaling in the prefrontal cortex in a rat model of depression and cortex-derived astrocytes |
Q88536544 | Replicability and Prediction: Lessons and Challenges from GWAS |
Q59790783 | Replicated associations of FADS1, MAD1L1, and a rare variant at 10q26.13 with bipolar disorder in Chinese population |
Q42271275 | Resting-State Functional Connectivity-Based Biomarkers and Functional MRI-Based Neurofeedback for Psychiatric Disorders: A Challenge for Developing Theranostic Biomarkers. |
Q37636582 | Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis. |
Q64073926 | Reverse GWAS: Using genetics to identify and model phenotypic subtypes |
Q91726009 | Risk Locus Identification Ties Alcohol Withdrawal Symptoms to SORCS2 |
Q40595654 | Risk factors and clinical characteristics of the depressive state induced by pegylated interferon therapy in patients with hepatitis C virus infection: A prospective study |
Q57796699 | Robust Findings From 25 Years of PSTD Genetics Research |
Q45072811 | Robust symptom networks in recurrent major depression across different levels of genetic and environmental risk |
Q52592883 | Role and Possible Mechanisms of Sirt1 in Depression. |
Q90433338 | SIRT1 Alleviates LPS-Induced IL-1β Production by Suppressing NLRP3 Inflammasome Activation and ROS Production in Trophoblasts |
Q37162737 | SIRT1 Mediates Depression-Like Behaviors in the Nucleus Accumbens. |
Q91297787 | SIRT1 in forebrain excitatory neurons produces sexually dimorphic effects on depression-related behaviors and modulates neuronal excitability and synaptic transmission in the medial prefrontal cortex |
Q57285505 | SIRT1 mediates obesity- and nutrient-dependent perturbation of pubertal timing by epigenetically controlling Kiss1 expression |
Q88770229 | SIRT1 rs3758391 and Major Depressive Disorder: New Data and Meta-Analysis |
Q37622643 | SNP-based heritability estimates of the personality dimensions and polygenic prediction of both neuroticism and major depression: findings from CONVERGE. |
Q90012640 | Sample Size for Successful Genome-Wide Association Study of Major Depressive Disorder |
Q48048867 | Seeking an objective diagnosis of depression |
Q39610291 | Serum proteomic profiles of depressive subtypes |
Q96577383 | Sex differences in the genetic architecture of depression |
Q37150882 | Sex-dependent adaptive changes in serotonin-1A autoreceptor function and anxiety in Deaf1-deficient mice |
Q47641958 | Sex-specific transcriptional signatures in human depression |
Q37510160 | Shared Genetics and Couple-Associated Environment Are Major Contributors to the Risk of Both Clinical and Self-Declared Depression |
Q90170283 | Shared genetic etiology underlying Alzheimer's disease and major depressive disorder |
Q89884949 | Shared genetic susceptibilities for irritable bowel syndrome and depressive disorder in Chinese patients uncovered by pooled whole-exome sequencing |
Q58707338 | Sirtuins in Neuroendocrine Regulation and Neurological Diseases |
Q26747309 | Somatic mutations in disorders with disrupted brain connectivity |
Q40842173 | Somatic, positive and negative domains of the Center for Epidemiological Studies Depression (CES-D) scale: a meta-analysis of genome-wide association studies |
Q47136255 | Statistical methods to detect pleiotropy in human complex traits |
Q35854307 | Substantial DNA methylation differences between two major neuronal subtypes in human brain |
Q38687599 | Systems Genomics Support for Immune and Inflammation Hypothesis of Depression. |
Q94558752 | TRPV6 variants confer susceptibility to chronic pancreatitis in the Chinese population |
Q89747287 | Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder |
Q57482794 | The 7q11.23 Protein DNAJC30 Interacts with ATP Synthase and Links Mitochondria to Brain Development |
Q26766465 | The Adapting Mind in the Genomic Era |
Q64071776 | The Antidepressant-like Effect of Flavonoids from Seeds in Chronic Restraint Stress Mice via Modulation of Monoamine Regulatory Pathways |
Q37575275 | The Association of Genetic Predisposition to Depressive Symptoms with Non-suicidal and Suicidal Self-Injuries |
Q30250052 | The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice |
Q33866563 | The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder |
Q98735784 | The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms |
Q47745954 | The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder |
Q38779701 | The Genetic Architecture of Major Depressive Disorder in Han Chinese Women |
Q28396166 | The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders |
Q37666098 | The Genetics-Driven Revival in Neuropsychiatric Drug Development. |
Q40619240 | The Interplay Between Risky Sexual Behaviors and Alcohol Dependence: Genome-Wide Association and Neuroimaging Support for LHPP as a Risk Gene |
Q60046051 | The Mitochondrion as Potential Interface in Early-Life Stress Brain Programming |
Q30854997 | The PHF21B gene is associated with major depression and modulates the stress response. |
Q39305206 | The association of childhood maltreatment with depression and anxiety is not moderated by the oxytocin receptor gene. |
Q39313687 | The brain, sirtuins, and ageing |
Q52147506 | The cellular target of antidepressants. |
Q45074070 | The centrality of DSM and non-DSM depressive symptoms in Han Chinese women with major depression |
Q91825121 | The depression GWAS risk allele predicts smaller cerebellar gray matter volume and reduced SIRT1 mRNA expression in Chinese population |
Q37613415 | The gender-specific association of rs334558 in GSK3β with major depressive disorder |
Q48045533 | The genetic basis of the comorbidity between cannabis use and major depression |
Q64091430 | The genetics of depression: successful genome-wide association studies introduce new challenges |
Q91272520 | The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine |
Q38659363 | The impact of epigenomic next-generation sequencing approaches on our understanding of neuropsychiatric disorders |
Q38790294 | The potential of genetic and gene expression analysis in the diagnosis of neuropsychiatric disorders |
Q58450463 | The protein histidine phosphatase LHPP is a tumour suppressor. |
Q39030396 | The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders |
Q39246908 | The schizophrenia susceptibility gene ZNF804A confers risk of major mood disorders |
Q35994785 | The successful search for genetic loci associated with depression |
Q38676034 | The utility of empirically assigning ancestry groups in cross-population genetic studies of addiction |
Q38446393 | Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder |
Q64071904 | Transcriptome Analysis on Maternal Separation Rats With Depression-Related Manifestations Ameliorated by Electroacupuncture |
Q90659266 | Translating GWAS findings into therapies for depression and anxiety disorders: gene-set analyses reveal enrichment of psychiatric drug classes and implications for drug repositioning |
Q45068646 | Transmission of alcohol use disorder across three generations: a Swedish National Study |
Q37282393 | UGT2B28 genomic variation is associated with hepatitis B e-antigen seroconversion in response to antiviral therapy |
Q37223246 | Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depression |
Q64444724 | Uncovering the Genetic Architecture of Major Depression |
Q90324756 | Unraveling the genetic architecture of major depressive disorder: merits and pitfalls of the approaches used in genome-wide association studies |
Q26782991 | Using GWAS to identify genetic predisposition in hepatic autoimmunity |
Q89939344 | Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population |
Q90700111 | Very low-depth whole-genome sequencing in complex trait association studies |
Q91895847 | Whole-Genome Sequencing Identifies the Egl Nine Homologue 3 (egln3/phd3) and Protein Phosphatase 1 Regulatory Inhibitor Subunit 2 (PPP1R2P1) Associated with High-Altitude Polycythemia in Tibetans at High Altitude |
Q47955566 | Whole-genome single nucleotide variant distribution on genomic regions and its relationship to major depression |
Q38443715 | Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity |
Q40213493 | Widespread Allelic Heterogeneity in Complex Traits |
Q34550161 | pHisphorylation: the emergence of histidine phosphorylation as a reversible regulatory modification |
Q54957019 | β2-microglobulin induces depressive- and anxiety-like behaviors in rat. |
Search more.